CNY 3990.00
2周
LRRC50 mouse monoclonal antibody, clone OTI3A1 (formerly 3A1), Biotinylated
Applications | WB |
Reactivities | Human |
CNY 3990.00
2周
LRRC50 mouse monoclonal antibody, clone OTI3A1 (formerly 3A1), Biotinylated
Applications | WB |
Reactivities | Human |
CNY 3990.00
2周
LRRC50 mouse monoclonal antibody, clone OTI5F8 (formerly 5F8), HRP conjugated
Applications | WB |
Reactivities | Human |
CNY 3990.00
2周
LRRC50 mouse monoclonal antibody, clone OTI3A1 (formerly 3A1), HRP conjugated
Applications | WB |
Reactivities | Human |
CNY 3990.00
2周
LRRC50 mouse monoclonal antibody, clone OTI3E2 (formerly 3E2), HRP conjugated
Applications | WB |
Reactivities | Human |
LRRC50 mouse monoclonal antibody, clone OTI3F9 (formerly 3F9)
Applications | FC, WB |
Reactivities | Human, Rat, Monkey, Mouse |
Transient overexpression lysate of leucine rich repeat containing 50 (LRRC50)
Tag | C-Myc/DDK |
Expression Host | HEK293T |
LRRC50 mouse monoclonal antibody, clone OTI2C4 (formerly 2C4)
Applications | FC, WB |
Reactivities | Human, Dog, Rat, Monkey, Mouse |
LRRC50 mouse monoclonal antibody, clone OTI4E4 (formerly 4E4)
Applications | IF, WB |
Reactivities | Human |
LRRC50 mouse monoclonal antibody, clone OTI4H3 (formerly 4H3)
Applications | WB |
Reactivities | Human, Rat, Monkey, Mouse |
LRRC50 mouse monoclonal antibody, clone OTI3B10 (formerly 3B10)
Applications | WB |
Reactivities | Human, Dog |
Transient overexpression of DNAAF1 in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
DNAAF1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Format | Lentiviral plasmids |
Vector | pGFP-C-shLenti |
DNAAF1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pRS |
LRRC50 mouse monoclonal antibody, clone OTI5F8 (formerly 5F8)
Applications | WB |
Reactivities | Human |
LRRC50 mouse monoclonal antibody, clone OTI3A1 (formerly 3A1)
Applications | WB |
Reactivities | Human |